Sanford Research will lead a multi-state effort across the upper rural Midwest to study the long-term effects of COVID-19 as part of the National Institutes of Health (NIH) RECOVER initiative.
Dr. Susan Hoover, infectious disease physician at Sanford Health, and Lora Black, RN, MPH, executive director of clinical research at Sanford Health, are leading the Sanford Research Post-SARS-CoV-2 Cohort at sites across the Sanford Health footprint.
Dr. Hoover and Black will serve as co-principal investigators on the study, in collaboration with the Dakota Community Collaborative on Translational Activity (DaCCoTA) and West Virginia University through the iSCORE consortium.
Sanford Research is one of more than 30 research teams across the country participating in theNIH Researching COVID to Enhance Recovery (RECOVER)initiative, which seeks to understand, treat and prevent post-acute sequelae of SARS-CoV-2 infection (PASC). PASC refers to symptoms that persist for weeks or months after the acute infection and is commonly referred to as “long COVID.”
COVID recovery time varies
Recovery from COVID-19 varies from person to person. Many people make a full recovery, but others continue to experience symptoms related to the infection or develop new symptoms over time that can adversely affect overall quality of life. PASC symptoms may involve multiple organs and systems, and can include pain, headaches, fatigue, shortness of breath, “brain fog,” chronic cough, sleep disturbances, anxiety, depression, and fever.
“There are a wide variety of post-COVID symptoms and not all patients suffer the same problems,” said Dr. Susan Hoover. “It is essential that we understand more about these conditions to try and alleviate the suffering experienced by people who have had COVID-19.”
“As we move ahead in the management of this pandemic, a major challenge we will face is the impact of long-term effects (PASC) following SARS-CoV-2 infection,” said Black. “Understanding more about the condition, various presentations in patients, and impact on quality of life and chronic disease will help clinicians and researchers design interventions that may alleviate suffering by those affected with PASC.”
Enrolling COVID patients now
桑福德研究团队正在招募经历过或处于COVID-19急性期的个人，包括来自弱势群体、老年人和服务不足人群的成年人，以及代表不同种族和民族的人，参与和登记参加恢复研究。桑福德研究公司特别感兴趣的是招募那些在过去30天内被诊断出COVID-19的人，或在过去30天内经历了COVID-19症状并检测呈阴性的人。
All participants will undergo clinical evaluations, answer questionnaires, take detailed exams and undergo diagnostic procedures. The data and samples collected will become part of the larger RECOVER database of tens of thousands of individuals nationwide.
According to theCenters for Disease Control and Prevention (CDC) COVID Data Tracker, as of March 2022, more than 79 million people in the United States have been infected with the SARS-CoV-2 virus.
To enroll in the study, you can call the Sanford Research office at (605) 312-3300 or email them directly atCOVID_Research@sanfordhealth.org.
Information in this story was accurate when it was posted. As the COVID-19 pandemic changes, scientific understanding and guidelines may have changed since the original publication date.
Learn more
- What we’ve learned about hybrid immunity, long COVID
- COVID-19 Q&A: Sanford Research on clinical trials, vaccines
- Sanford Health reflects on two years in a pandemic
…
Posted InCoronavirus,Leadership in Health Care,Research
